title: Steroid sulfatase, arylsulfatases A and B, galactose-6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity.
abstract: Sulfatase enzymes have important roles in metabolism of steroid hormones and of glycosaminoglycans (GAGs). The activity of five sulfatase enzymes, including steroid sulfatase (STS; arylsulfatase C), arylsulfatase A (ASA; cerebroside sulfatase), arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase), galactose-6-sulfatase (GALNS), and iduronate-2-sulfatase (IDS), was compared in six different mammary cell lines, including the malignant mammary cell lines MCF7, T47D, and HCC1937, the MCF10A cell line which is associated with fibrocystic disease, and in primary epithelial and myoepithelial cell lines established from reduction mammoplasty. The effects of estrogen hormones, including estrone, estradiol, estrone 3-sulfate, and estradiol sulfate on activity of these sulfatases were determined. The malignant cell lines MCF7 and T47D had markedly less activity of STS, ASB, ASA, and GAL6S, but not IDS. The primary myoepithelial cells had highest activity of STS and ASB, and the normal epithelial cells had highest activity of GALNS and ASA. Greater declines in sulfatase activity occurred in response to estrone and estradiol than sulfated estrogens. The study findings demonstrated marked variation in sulfatase activity and in effects of exogenous estrogens on sulfatase activity among the different mammary cell types.
authors.affiliation: Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States; Jesse Brown VAMC, Chicago, IL, United States.
authors.forename: Sumit
authors.initials: S
authors.lastname: Bhattacharyya
authors.forename: Joanne K
authors.initials: JK
authors.lastname: Tobacman
mesh_terms: D001192:Arylsulfatases / Q000378:metabolism*; D001940:Breast / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D001943:Breast Neoplasms / Q000201:enzymology; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D002811:Chondroitinsulfatases / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation; D004847:Epithelial Cells / Q000187:drug effects / Q000201:enzymology; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000201:enzymology; D006801:Humans; D007066:Iduronate Sulfatase / Q000378:metabolism*; D016133:Polymerase Chain Reaction / Q000379:methods; D043266:Steryl-Sulfatase / Q000378:metabolism*; D013997:Time Factors
chemical_list: D004967:Estrogens; D004958:Estradiol; D002811:Chondroitinsulfatases; D001192:Arylsulfatases; D007066:Iduronate Sulfatase; D043266:Steryl-Sulfatase; C102295:GALNS protein, human